Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vincent Medical Holdings Limited ( (HK:1612) ) just unveiled an announcement.
Vincent Medical Holdings has scheduled a board meeting for 25 March 2026 to review and approve its annual results for the year ended 31 December 2025, and to authorise the publication of those results. The board will also consider the payment of a final dividend, signalling potential returns for shareholders depending on the company’s performance.
The most recent analyst rating on (HK:1612) stock is a Buy with a HK$1.00 price target. To see the full list of analyst forecasts on Vincent Medical Holdings Limited stock, see the HK:1612 Stock Forecast page.
More about Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the medical sector. It is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a standard corporate governance structure for a listed medical products group.
Average Trading Volume: 851,431
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$632.9M
For an in-depth examination of 1612 stock, go to TipRanks’ Overview page.